参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/02/25 | 1,549 | 1,556 | 1,521 | 1,521 | -9 | -0.6% | 1,077,300 |
2021/02/24 | 1,559 | 1,562 | 1,522 | 1,530 | -42 | -2.7% | 1,552,400 |
2021/02/22 | 1,570 | 1,579 | 1,561 | 1,572 | +8 | +0.5% | 717,600 |
2021/02/19 | 1,568 | 1,577 | 1,553 | 1,564 | -15 | -0.9% | 1,000,800 |
2021/02/18 | 1,575 | 1,584 | 1,568 | 1,579 | +5 | +0.3% | 1,181,800 |
2021/02/17 | 1,592 | 1,602 | 1,566 | 1,574 | -23 | -1.4% | 1,385,700 |
2021/02/16 | 1,603 | 1,606 | 1,573 | 1,597 | -6 | -0.4% | 1,499,300 |
2021/02/15 | 1,622 | 1,627 | 1,593 | 1,603 | -13 | -0.8% | 1,290,100 |
2021/02/12 | 1,643 | 1,658 | 1,608 | 1,616 | -38 | -2.3% | 2,196,600 |
2021/02/10 | 1,670 | 1,677 | 1,639 | 1,654 | -35 | -2.1% | 1,620,300 |
2021/02/09 | 1,705 | 1,707 | 1,678 | 1,689 | -29 | -1.7% | 1,265,100 |
2021/02/08 | 1,709 | 1,743 | 1,702 | 1,718 | +13 | +0.8% | 1,357,600 |
2021/02/05 | 1,729 | 1,734 | 1,685 | 1,705 | -42 | -2.4% | 1,432,800 |
2021/02/04 | 1,748 | 1,754 | 1,735 | 1,747 | -7 | -0.4% | 501,800 |
2021/02/03 | 1,732 | 1,758 | 1,729 | 1,754 | +28 | +1.6% | 763,600 |
2021/02/02 | 1,745 | 1,749 | 1,717 | 1,726 | -19 | -1.1% | 602,200 |
2021/02/01 | 1,740 | 1,754 | 1,731 | 1,745 | +14 | +0.8% | 736,300 |
2021/01/29 | 1,718 | 1,756 | 1,716 | 1,731 | +16 | +0.9% | 1,357,900 |
2021/01/28 | 1,678 | 1,722 | 1,672 | 1,715 | -15 | -0.9% | 3,375,200 |
2021/01/27 | 1,711 | 1,739 | 1,708 | 1,730 | +30 | +1.8% | 1,181,400 |
2021/01/26 | 1,701 | 1,716 | 1,696 | 1,700 | +8 | +0.5% | 796,700 |
2021/01/25 | 1,686 | 1,694 | 1,677 | 1,692 | +13 | +0.8% | 673,200 |
2021/01/22 | 1,661 | 1,682 | 1,658 | 1,679 | -2 | -0.1% | 725,900 |
2021/01/21 | 1,690 | 1,714 | 1,679 | 1,681 | +3 | +0.2% | 1,192,800 |
2021/01/20 | 1,681 | 1,685 | 1,659 | 1,678 | -10 | -0.6% | 992,700 |
2021/01/19 | 1,715 | 1,715 | 1,682 | 1,688 | -23 | -1.3% | 772,700 |
2021/01/18 | 1,710 | 1,718 | 1,698 | 1,711 | +4 | +0.2% | 645,000 |
2021/01/15 | 1,705 | 1,720 | 1,697 | 1,707 | -9 | -0.5% | 907,800 |
2021/01/14 | 1,686 | 1,734 | 1,684 | 1,716 | +30 | +1.8% | 1,387,500 |
2021/01/13 | 1,684 | 1,693 | 1,667 | 1,686 | -13 | -0.8% | 1,309,900 |
2021/01/12 | 1,711 | 1,724 | 1,687 | 1,699 | +13 | +0.8% | 1,246,900 |
2021/01/08 | 1,665 | 1,688 | 1,662 | 1,686 | +15 | +0.9% | 1,205,300 |
2021/01/07 | 1,686 | 1,693 | 1,670 | 1,671 | +3 | +0.2% | 1,062,200 |
2021/01/06 | 1,648 | 1,681 | 1,647 | 1,668 | +17 | +1% | 744,300 |
2021/01/05 | 1,672 | 1,675 | 1,640 | 1,651 | -18 | -1.1% | 825,400 |
2021/01/04 | 1,680 | 1,682 | 1,652 | 1,669 | -6 | -0.4% | 502,300 |
2020/12/30 | 1,693 | 1,696 | 1,672 | 1,675 | -19 | -1.1% | 592,200 |
2020/12/29 | 1,665 | 1,699 | 1,658 | 1,694 | +41 | +2.5% | 853,200 |
2020/12/28 | 1,637 | 1,661 | 1,627 | 1,653 | +15 | +0.9% | 873,900 |
2020/12/25 | 1,647 | 1,651 | 1,633 | 1,638 | -14 | -0.8% | 483,100 |
2020/12/24 | 1,663 | 1,672 | 1,650 | 1,652 | -3 | -0.2% | 519,200 |
2020/12/23 | 1,675 | 1,677 | 1,647 | 1,655 | -1 | -0.1% | 1,017,100 |
2020/12/22 | 1,653 | 1,659 | 1,640 | 1,656 | -8 | -0.5% | 955,400 |
2020/12/21 | 1,686 | 1,689 | 1,646 | 1,664 | -17 | -1% | 1,084,100 |
2020/12/18 | 1,657 | 1,691 | 1,645 | 1,681 | +34 | +2.1% | 2,122,300 |
2020/12/17 | 1,672 | 1,673 | 1,631 | 1,647 | -24 | -1.4% | 1,654,900 |
2020/12/16 | 1,738 | 1,738 | 1,671 | 1,671 | -43 | -2.5% | 1,613,700 |
2020/12/15 | 1,720 | 1,727 | 1,708 | 1,714 | -3 | -0.2% | 1,091,500 |
2020/12/14 | 1,714 | 1,744 | 1,711 | 1,717 | +3 | +0.2% | 906,100 |
2020/12/11 | 1,708 | 1,723 | 1,692 | 1,714 | +6 | +0.4% | 722,600 |
1101~
1150
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 157,500円 | -2.0% | -7.3% | 2.41% | 15.39倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ロート | 253,900円 | +8.4% | +6.4% | 1.65% | 18.21倍 | 2.21倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
住友ファーマ | 144,000円 | -11.0% | +206.6% | 0.00% | 14.30倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
久光薬 | 429,900円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.11倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 364,900円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム